Clinical Trial Update: Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing intravitreal bevacizumab alone versus bevacizumab with triamcinolone for neovascular age-related macular degeneration; results/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• Kenalog (triamcinolone acetonide)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Neovascular Age-Related Macular Degeneration | Phase 3 | Status: UNKNOWN